FFCP PHASE2:Hg19::chr11:62439729..62439747,-
From FANTOM5_SSTAR
Jump to: navigation, search
| Short description: | p2@C11orf48 |
|---|---|
| Species: | Human (Homo sapiens) |
| DPI dataset: | Robust |
| TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
| DHS support(Yes/No): | Yes |
| Description: | CAGE_peak_2_at_C11orf48_5end |
| Coexpression cluster: | C173_Adipocyte_mature_skin_left_Hepatocyte_Osteoblast_adipose |
| Association with transcript: | -2bp_to_ENST00000528862_5end |
| EntrezGene: | C11orf48 |
| HGNC: | 28351 |
| UniProt: | E9PQ29 |
| Genome view: | ZENBU |
View on UCSC genome browser
Mouse over to see Genome browser image, Click image to go to Genome browser
CAGE Expression
| Sample | p2@C11orf48 |
|---|
0
50
100
150
200
250
300
350
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
| Ontology term | p-value | n |
|---|---|---|
| hematologic cancer | 1.93e-28 | 51 |
| immune system cancer | 1.93e-28 | 51 |
| leukemia | 4.99e-25 | 39 |
| myeloid leukemia | 4.57e-22 | 31 |
| disease of cellular proliferation | 6.61e-13 | 239 |
| cancer | 7.30e-13 | 235 |
| organ system cancer | 1.61e-10 | 137 |
Showing 1 to 7 of 7 entries
